Journal warns of UK cosmetic surgery risks
Cosmetic surgery patients in the UK are increasingly in danger, according to reports in a specialist medico-legal journal. In a special edition of Clinical...
Nexavar price ‘simply too high’, says NICE
NICE has issued draft guidance against the use of Nexavar (sorafenib) for advanced hepatocellular carcinoma, which is now open for consultation. The indication under...
NICE launches medtech evaluation programme
NICE has launched a programme to evaluate innovative medical technologies, supported by a new Medical Technologies Advisory Committee. The Evaluation Pathway Programme for Medical...
Innovation Hub appoints Marketing Co-ordinator
Health Enterprise East (HEE), the region's NHS Innovation Hub, has appointed Chris Armstrong as Marketing Co-ordinator. His role will be to raise the...
SSC makes internal promotion
Healthcare and scientific recruitment consultancy Scientific Staff Consultants (SSC) has appointed Sally McElhone as Commercial Manager. Sally has been with SSC for over four...
Manx medtech firm goes global
Isle of Man-based company Rhesus Healthcare has formed a joint venture company with 3F Medical Systems, based in Shanghai, China. The new company, Rhesus-3F...
New joint industry ruling for greater transparency
Companies will be obliged to disclose information on all clinical trials in patients, as part of a new Joint Position from the Council of...
Demand growing for treatments for drug resistant HIV strains, finds Frost & Sullivan
The HIV/AIDS market in Europe will exhibit strong growth due to the introduction of novel drug classes and increasing efforts to achieve high diagnosis...
JAOtech strengthens European business
Medical 'smart terminal' specialist JAOtech has opened its European Sales HQ in the Netherlands and appointed Bart Dolsma as European Sales Director. Dolsma will...
GPs ignoring diarrhoea guidelines
Guidelines on the management of acute diarrhoea are not always being followed by GPs. There is also a disconnect between what patients with acute...
Latest articles
GlaxoSmithKline’s Zejula (niraparib) approved for treatment of ovarian cancer
The European Commission has approved GlaxoSmithKline's (GSK) Zejula (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, as first-line monotherapy maintenance treatment for adult...
Ten top tips for pharma and healthcare to avoid data breaches
Every organisation is a software organisation but for healthcare providers and pharmaceutical organisations, the stakes are high when it comes to data breaches. In...
TherapeutAix expands R&D network to Alderley Analytical and Peak Proteins
Life sciences consultancy, TherapeutAix, has added contract research organisations (CROs), Alderley Analytical and Peak Proteins to its global R&D network. The partnership will form...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
GlaxoSmithKline’s Zejula (niraparib) approved for treatment of ovarian cancer
The European Commission has approved GlaxoSmithKline's (GSK) Zejula (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, as first-line monotherapy maintenance treatment for adult...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
Pfizer suffers huge data breach on unsecured cloud storage
Global pharmaceutical giant Pfizer Inc. has suffered a huge data breach, with patient information found exposed on unsecured cloud storage. The exposed data was...